20/20 BiolabsAIDX
13F holders, Q1 2026 (March 31)7holders
1famous investor
$1.88avg. 13F price*
At the end of Q1 2026, 7 institutions reported holding 20/20 Biolabs Inc. (AIDX) in their 13F filings. The largest holders were Cresset Asset Management, LLC ($497K), Citadel Advisors ($31K) and XTX Topco Ltd ($19K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- 20/20 Biolabs Inc.
- CUSIP
- 90138K101
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $565K |
| Exits | 0 | $0 |
Ownership 7 holders
| Cresset Asset Management, LLC | 0.00% | New | 264,368 | $497K |
| Citadel Advisors | 0.00% | New | 16,227 | $31K |
| XTX Topco Ltd | 0.00% | New | 10,329 | $19K |
| UBS Group AG | 0.00% | New | 8,314 | $16K |
| MAI Capital Management | 0.00% | New | 1,000 | $2K |
| Toth Financial Advisory Corp. | 0.00% | New | 157 | $296 |
| Allworth Financial LP | 0.00% | New | 30 | $57 |
"% of holder's portfolio" is AIDX's weight in each manager's 13F, not the share of 20/20 Biolabs Inc. the manager owns.